| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.24 | 2e-07 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0007 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |